Cubist Pharmaceuticals (NASDAQ: CBST ) has appointed a new chief financial officer. The new top finance executive at the company is Michael Tomsicek, who replaces the outgoing David McGirr.
Tomsicek has been senior vice president and deputy CFO since July of last year. He joined the company in 2010 as vice president of corporate finance. Before that, he worked for eight years at General Electric Healthcare, serving as finance manager of global operations, CFO of the diagnostic ultrasound segment, and CFO of the global ultrasound product group.
Tomsicek's predecessor, McGirr, will become senior advisor to the chief executive officer and retire next year.